- $169.87m
- $208.73m
- $163.31m
- 44
- 40
- 77
- 53
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 124 | 135 | 148 | 176 | 163 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 140 | 156 | 175 | 194 | 187 |
Operating Profit | -16.4 | -20.5 | -27.5 | -17.3 | -23.6 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -16.2 | -20.2 | -27.3 | -17 | -22.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -13.8 | -19.3 | -25 | -16.7 | -20.5 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -13.8 | -19.3 | -25 | -16.7 | -20.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -13.8 | -19.3 | -25 | -16.7 | -20.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.931 | -1.3 | -1.68 | -1.12 | -1.36 |
Special Dividends per Share |